Paradise Genomics

Paradise Genomics is a private, pre-revenue diagnostics company leveraging over 30 years of collective founder experience in genomics to discover novel biomarker signatures. The company emerged from GenUs BioSystems, a contract lab with a strong track record, and now aims to validate and commercialize its discoveries through partnerships with diagnostic and pharmaceutical companies. Its core value proposition is a proprietary bioinformatics process that claims unmatched sensitivity and precision in unlocking a unique region of the transcriptome for actionable genomic data.

Proprietary gene expression analysis and bioinformatics platform for biomarker discovery from blood and tissue, leveraging microarray technology and a unique bioinformatics protocol to identify novel transcriptomic signatures.

Paradise Genomics competes in a crowded biomarker discovery field against large diagnostic companies (e.g., Exact Sciences, Guardant Health), specialized startups, and academic institutions. Its differentiation is its focused discovery platform and legacy of quality from GenUs BioSystems, but it must prove its signatures are superior or complementary to existing approaches.